How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapies.

Autor: Hehlmann R; Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany. hehlmann.eln@gmail.com.; ELN Foundation, Weinheim, Germany. hehlmann.eln@gmail.com., Lauseker M; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie - IBE, Medizinische Fakultät, LMU München, München, Germany.

Publikováno v: Leukemia [Leukemia] 2024 Feb; Vol. 38 (2), pp. 465-466. Date of Electronic Publication: 2024 Jan 13.

European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia.

Autor: Cross NCP; Faculty of Medicine, University of Southampton, Southampton, UK. ncpc@soton.ac.uk., Ernst T; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany., Branford S; Centre for Cancer Biology and SA Pathology, Adelaide, SA, Australia., Cayuela JM; Laboratory of Hematology, University Hospital Saint-Louis, AP-HP and EA3518, Université Paris Cité, Paris, France., Deininger M; Huntsman Cancer Center Salt Lake City, Salt Lake City, UT, USA., Fabarius A; III. Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany., Kim DDH; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Machova Polakova K; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Radich JP; Fred Hutchinson Cancer Center, Seattle, WA, USA., Hehlmann R; III. Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany.; ELN Foundation, Weinheim, Germany., Hochhaus A; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany., Apperley JF; Centre for Haematology, Imperial College London, London, UK.; Department of Clinical Haematology, Imperial College Healthcare NHS Trust, London, UK., Soverini S; Department of Medical and Surgical Sciences, Institute of Hematology 'Lorenzo e Ariosto Seràgnoli', University of Bologna, Bologna, Italy.

Publikováno v: Leukemia [Leukemia] 2023 Nov; Vol. 37 (11), pp. 2150-2167. Date of Electronic Publication: 2023 Oct 04.

Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study.

Autor: Niederwieser D; University Leipzig, Germany; Aichi Medical University School of Medicine, Nagakute, Japan; KaunoKlinikos University of Health Sciences, Kaunas, Lithuania. dietger@medizin.uni-leipzig.de., Hasenclever D; Institute for Medical Informatics, Statistics and Epidemiology (IMISE) ) in cooperation with the Clinical trial Centre (ZKS), University of Leipzig, Germany,04107 Leipzig. dirk.hasenclever@imise.uni-leipzig.de., Berdel WE; Universitätsklinikum, 48149 Münster. berdel@uni-muenster.de., Biemond BJ; Amsterdam University Medical Centers, University of Amsterdam, Amsterdam. b.j.biemond@amsterdamumc.nl., Al-Ali H; University Hospital, Halle. haifa.al-ali@uk-halle.de., Chalandon Y; Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Bern. yves.chalandon@hcuge.ch., Van Gelder M; Maastricht University Medical Center, 6202 AZ Maastricht. m.van.gelder@mumc.nl., Junghanß C; Universitätsklinikum Rostock, 18057 Rostock. christian.junghanss@med.uni-rostock.de., Gahrton G; Dep. of Medicine, Karolinska Institute, Huddinge 141 86 Stockholm Sweden. gosta.gahrton@ki.se., Hänel M; Klinikum Chemnitz gGmbH, Flemmingstraße 2, 09116 Chemnitz. m.haenel@skc.de., Hehlmann R; Medizinische Fakultät Mannheim, Universität Heidelberg, and European Leukemia Net Foundation, Weinheim, Germany Hehlmann. ELN@gmail.com., Heinicke T; Department of Hematology and Oncology, Otto-von-Guericke University, Magdeburg. thomas.heinicke@med.ovgu.de., Hochhaus A; Universitätsklinikum Jena, Jena. Andreas.Hochhaus@med.uni-jena.de., Iacobelli S; Università di Roma 'Tor Vergata', Dipartimento di Biologia - 00133 Roma. simona.iacobelli@ebmt.org., Kooy RVM; Isala Clinic Zwolle, Dokter van Heesweg 2, 8025 AB Zwolle. rienvmk@gmail.com., Kröger N; University Medical Center Hamburg/Germany. nkroeger@uke.de., Janssen J; Amsterdam University Medical Centers, University of Amsterdam, Amsterdam. j.janssen@amsterdamumc.nl., Jentzsch M; University of Leipzig. Madlen.Jentzsch@medizin.uni-leipzig.de., Breywisch F; Department of Hematology, Oncology and Palliative Care, Ernst Von Bergmann Hospital, Potsdam. frank.breywisch@klinikumevb.de., Mohty M; Sorbonne University, Hospital Saint Antoine Department of Hematology, INSERM UMRs938, Paris, France mohamad. mohty@inserm.fr., Masouridi-Levrat S; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva. Stavroula.Masouridi@hcuge.ch., Ossenkoppele G; VU University Medical Center, 1081 HV Amsterdam, Netherlands. g.ossenkoppele@amsterdamumc.nl., Passweg J; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; Klinik für Hämatologie, Universitätsspital Basel, Petersgraben 4, CH-4031 Basel. jakob.passweg@usb.ch., Pönisch W; University Leipzig. Wolfram.Poenisch@medizin.uni-leipzig.de., Schetelig J; University Hospital, TU Dresden. Johannes.Schetelig@uniklinikum-dresden.de., Schliemann C; University Hospital Münster, Department of Medicine A, 48149 Münster. christoph.schliemann@ukmuenster.de., Schwind S; University of Leipzig. Madlen.Jentzsch@medizin.uni-leipzig.de., Stelljes M; University Hospital Münster, Department of Medicine A, 48149 Münster,. Germany.stelljes@uni-muenster.de., Verdonck LF; Isala Clinic Zwolle, Dokter van Heesweg 2, 8025 AB Zwolle, Netherlands. l.verdonck@kpnmail.nl., Vucinic V; University of Leipzig. Vladan.Vucinic@medizin.uni-leipzig.de., Löwenberg B; Erasmus University Medical Center Rotterdam and Erasmus MC Cancer Institute, 3015 GD Rotterdam. b.lowenberg@erasmusmc.nl., Cornelissen J; Erasmus University Medical Center Rotterdam and Erasmus MC Cancer Institute, 3015 GD Rotterdam. j.cornelissen@erasmusmc.nl.

Publikováno v: Haematologica [Haematologica] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.

Oncornavirus-Like Particles in Human Skin Cancers

Autor: Hehlmann, R., Spiegelman, S.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 1975 Sep 01. 72(9), 3697-3700.

Externí odkaz: https://www.jstor.org/stable/65470

Viral-Related RNA in Hodgkins' Disease and other Human Lymphomas

Autor: Hehlmann, R., Kufe, D., Spiegelman, S.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 1972 Jul 01. 69(7), 1727-1731.

Externí odkaz: https://www.jstor.org/stable/61879